Bil Vyapar Ltd is a Specialty Chemicals company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Bil Vyapar Ltd makes money through Manufactured commodity sales, Value-added products, Exports or institutional demand in Specialty Chemicals. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Chemicals.
Create a free account to view momentum, moving averages, and delivery signals.
Upgrade to view volatility, drawdown, factor, and risk metrics.
| Period | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | ₹4,736 Cr | ₹4,331 Cr | ₹3,784 Cr | |||||||||
| Expenses | ₹4,452 Cr | ₹4,182 Cr | ₹3,468 Cr | |||||||||
| Operating Profit | ₹284 Cr | ₹149 Cr | ₹316 Cr | |||||||||
| OPM % | 6.0% | 3.4% | 8.4% | |||||||||
| Other Income | ₹-114 Cr | ₹32 Cr | ₹26 Cr | |||||||||
| Depreciation | ₹300 Cr | ₹258 Cr | ₹257 Cr | |||||||||
| Interest | ₹622 Cr | ₹598 Cr | ₹643 Cr | |||||||||
| Profit Before Tax | ₹-752 Cr | ₹-675 Cr | ₹-557 Cr | |||||||||
| Tax | ₹-752 Cr | ₹-675 Cr | ₹-557 Cr | |||||||||
| Net Profit | ₹-663 Cr | ₹-649 Cr | ₹-432 Cr | |||||||||
| EPS (₹) | -220.7 | -216.3 | -140.9 | |||||||||
| Dividend Payout % | -1.36% | -1.39% | 0% |
Register free to see 9 more years.
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ||||||||
| Expenses | ₹1 Cr | ₹146 Cr | ₹1 Cr | ₹1 Cr | ||||||||
| Operating Profit | ₹-1 Cr | ₹-145 Cr | ₹-1 Cr | ₹-1 Cr | ||||||||
| OPM % | -183.3% | -34,626.2% | 0.0% | 0.0% | ||||||||
| Depreciation | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ||||||||
| Interest | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ||||||||
| Net Profit | ₹-2 Cr | ₹-146 Cr | ₹-1 Cr | ₹-1 Cr | ||||||||
| EPS (₹) | -0.5 | -46.4 | -0.2 | -0.2 |
Register free to see 8 more quarters.
| Period | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity Capital | ₹30 Cr | ₹30 Cr | ₹31 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reserves | ₹-319 Cr | ₹-1,173 Cr | ₹-741 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Borrowings | ₹5,127 Cr | ₹5,998 Cr | ₹6,342 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other Liabilities | ₹2,118 Cr | ₹1,723 Cr | ₹2,273 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total Liabilities | ₹6,955 Cr | ₹6,579 Cr | ₹7,905 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Assets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fixed Assets | ₹5,040 Cr | ₹4,612 Cr | ₹5,804 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investments | ₹0 Cr | ₹0 Cr | ₹30 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Receivables | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Inventory | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cash & Equivalents | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other Assets | ₹1,563 Cr | ₹1,676 Cr | ₹1,813 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total Assets | ₹6,955 Cr | ₹6,579 Cr | ₹7,905 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Register free to see 9 more years.
| Period | Operating | Investing | Financing | Net Cash Flow |
|---|---|---|---|---|
| Mar 2015 | ₹214 Cr | ₹-245 Cr | ₹-53 Cr | — |
| Mar 2016 | ₹-42 Cr | ₹3 Cr | ₹165 Cr | — |
| Mar 2017 | ₹340 Cr | ₹-173 Cr | ₹-266 Cr | — |
| Mar 2018 | ||||
| Mar 2019 | ||||
| Mar 2020 | ||||
| Mar 2021 | ||||
| Mar 2022 | ||||
| Mar 2023 | ||||
| Mar 2024 | ||||
| Mar 2025 |
Register free to see 9 more years.
No dividend history available.
No corporate actions recorded.
| Company | M.Cap | P/E | ROE | 1Y Return |
|---|---|---|---|---|
| Asian Paints Ltd | ₹2,49,762 Cr | 64.8 | 0.00% | -6.05% |
| PIDILITE | ₹1,49,379 Cr | 61.1 | +23.52% | -4.63% |
| Berger Paints India Ltd | ₹60,078 Cr | 53.3 | +17.23% | -4.67% |
| Aarti Industries Ltd | ₹16,734 Cr | 39.9 | +7.25% | +17.41% |
| Aarti Surfactants Ltd | ₹330 Cr | 18.4 | 0.00% | -17.04% |
Create a free account to see institutional ownership snapshots.
Create a free account to view recent director and promoter trades.
Create a free account to view recent institutional deal activity.
Create a free account to view analyst estimate summaries.
Create a free account to view ESG risk and governance summaries.
Upgrade to view issuer ratings, instruments, outlooks, and rating history.
rupiya.io is for research and education only. Metrics shown are not investment advice. Validate with SEBI-regulated disclosures before acting.